Fast, Flexible and Creative Omics Data Analysis for Cancer Drug Discovery
✅ Rapid data retrieval and reanalysis.
✅ Efficient Biomarker Identification
✅ Simplified insight extraction
Client Profile
Plexium is the premier, next-generation targeted protein degradation (TPD) company, leading the way in the rational design and discovery of monovalent protein degraders across a wide range of modalities.
The company has developed a comprehensive approach toward Targeted Protein Degradation, powered by a proprietary best-in-class platform, designed to identify novel small molecules that induce selective degradation of drug target proteins through E3 ligase mediated proteasomal degradation.
From molecular glues to monovalent degraders, Plexium is advancing a pipeline of novel targeted protein degraders for the treatment of cancer, neurodegeneration, and other diseases.
Plexium has implemented Omics Playground so that data analyses can be carried out faster, flexibly, and creatively.
Challenges
Prioritizing Speed
The biotech industry requires fast data analysis as it has to compete with larger pharmaceutical companies.
Avoiding Siloed Data
It is crucial for drug development to avoid isolated, siloed data that are difficult to combine.
Efficient Data Revisiting
Fast access to data is essential, which requires the efficient retrieval of information from both old and new data sets.
Results with Omics Playground
Speed Enhancement
Rapid data retrieval and reanalysis, reducing the time to answer specific questions from days to a mere 7 minutes.
Efficient Biomarker Identification
Streamlined process for obtaining biomarkers in just 15 minutes, compared to the previous time-consuming workflow, which can take up to 3 days.
Simplified Data Extraction
Simplification of complex data for easy understanding and efficient communication. A new, improved way of intuitively analyzing data that leads to better results.
I get a figure, create a slide deck, and it’s done. Boom.
It's a real time-saver. »
